Improvement of peritoneal ultrafiltration with peritoneal dialysis solution buffered with bicarbonate/lactate mixture

Peritoneal Dialysis International

Volumn 26, Issue 3, 2006, Pages 353-359

  Simonsen, Ole ^a   Sterner, Gunnar ^a   Carlsson, Ola ^b   Wieslander, Anders ^b   Rippe, Bengt ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Gambro AB   (Sweden)

Author keywords

Bicarbonate; Glucose degradation products; Lactate; pH; Solute transport; Ultrafiltration

Indexed keywords

ALBUMIN I 125; BICARBONATE; BUFFER; CALCIUM CHLORIDE; CREATININE; GAMBROSOL TRIO; GLUCOSE; GLUCOSE DEGRADATION PRODUCT; LACTIC ACID; MAGNESIUM CHLORIDE; NEUTRAL; PD BIO; PERITONEAL DIALYSIS FLUID; PHOSPHATE; SODIUM CHLORIDE; UREA;

ABSORPTION; ADULT; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CALCULATION; CHEMICAL COMPOSITION; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIALYSATE LEVEL; DIALYSIS EQUIPMENT AND SUPPLIES; DRUG FORMULATION; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; INTERSTITIAL NEPHRITIS; KIDNEY AMYLOIDOSIS; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; LYMPH; NEPHROSCLEROSIS; PERITONEAL CATHETER; PERMEABILITY; PH; PHOSPHATE BLOOD LEVEL; PLASMA CLEARANCE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REDUCTION; STANDARDIZATION; STATISTICAL SIGNIFICANCE; ULTRAFILTRATION; UREA BLOOD LEVEL; VASODILATATION;

EID: 33748422221     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600313     Document Type: Article

References (21)

1. Rippe B, Simonsen O, Wieslander A, Landgren C. Clinical and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis. Perit Dial Int 1997;17:27-34.
2. Rippe B, Simonsen O, Heimbürger O, Christensson A, Haraldsson B, Stelin G, et al. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001; 59:348-57.
3. Simonsen O, Wieslander A, Venturoli D, Carlsson O, Rippe B. Mass transfer of calcium across the peritoneum at three different peritoneal dialysis fluid Ca and glucose concentrations. Kidney Int 2003; 64:208-15.
4. Waniewski J, Heimbürger O, Werynski A, Lindholm B. Aqueous solute concentrations and evaluation of mass transport coefficients in peritoneal dialysis. Nephrol Dial Transplant 1992; 7:50-6.
5. Zakaria ER, Rippe B. Intraperitoneal fluid volume changes during peritoneal dialysis in the rat. Indicator dilution vs volumetric measurements. Blood Purif 1995; 13:255-70.
6. Rippe B, Krediet RT. Peritoneal physiology - transport of solutes. In: Gokal R, Nolph KD, eds. The Textbook of Peritoneal Dialysis. Dordrecht: Kluwer Academic Publishers; 1994:68-132.
7. Rippe B, Stelin G, Ahlmén J. Lymph flow from the peritoneal cavity in CAPD patients. In: Maher JF, Winchester JF, eds. Frontiers in Peritoneal Dialysis. New York: Field, Rich and Associates; 1986: 24-30.
8. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al. The Euro-Balance Trial: The effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 2004; 66:408-18.
9. Tranaeus A. A Long-term study of bicarbonate/lactate-based peritoneal dialysis solution - clinical benefits. The Bicarbonate/Lactate Study Group. Perit Dial Int 2000; 20: 516-23.
10. Montenegro J, Saracho R, Martinez I, Munos R, Ocharan J. Peritoneal transport with 3 different peritoneal solutions [Abstract]. Nephrol Dial Transplant 2003; 18:216.
11. Schambye HT, Pedersen FB, Wang P. Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluents. Adv Perit Dial 1992; 8:42-6.
12. Schambye HT. Effect of different buffers on the biocompatibility of CAPD solutions. Perit Dial Int 1996; 16(Suppl 1):S130-6.
13. Mactier RA, Sprosen TS, Gokal R. Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int 1998; 53:1061-7.
14. Folkow B, Neil E. Circulation. New York: Oxford University Press; 1971; 285-306.
15. Carlsson C, Kirchgessner J, Passlick-Deetjen J, Rippe A, Rippe B. Peritoneal dialysis (PD) solutions and peritoneal exchange. Nieren- und Hochdruckkrankheiten 1997; 26(Suppl 1):S20-3.
16. Miller FN, Nolph KD, Joshua IG, Wiegman DL, Harris PD, Andersen DB. Hyperosmolality, acetate, and lactate: dilatory factors during peritoneal dialysis. Kidney Int 1981; 20:397-402.
17. Rippe B, Stelin G, Haraldsson B. Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 1991; 40: 315-25.
18. Krediet RT, Lindholm B, Rippe B. Pathophysiology of peritoneal membrane failure. Perit Dial Int 2000; 20(Suppl 4): S22-42.
19. Rippe B, Venturoli D, Simonsen O, de Arteaga J. Fluid and electrolyte transport across the peritoneal membrane during CAPD. Perit Dial Int 2004; 24:10-27.
20. Rosengren B-I, Rippe B. Blood flow Limitation in vivo of small solute transfer during peritoneal dialysis in rats. J Am Soc Nephrol 2003; 14:1599-604.
21. Mortier S, De Vriese AS, Van de Voorde J, Schaub TP, Passlick-Deetjen J, Lameire NH. Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products. J Am Soc Nephrol 2002; 13:480-9.